Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

By Seystahl Katharina   Weller Michael  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 605-617

Informa Healthcare

Access to resources Recommend Favorite

Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2

By Detillieux Karen A   Cattini Peter A   Kardami Elissavet  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 12, 2004-12 ,pp. : 1044-1052

NRC Research Press

Access to resources Recommend Favorite

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

By Tomao Federica   Papa Anselmo   Rossi Luigi   Caruso Davide   Zoratto Federica   Benedetti Panici Pierluigi   Tomao Silverio  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 37-53

Informa Healthcare

Access to resources Recommend Favorite

Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2713-2719

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF and Colon Cancer Growth Beyond Angiogenesis: Does VEGF Directly Mediate Colon Cancer Growth Via a Non-angiogenic Mechanism?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1041-1044

Bentham Science Publishers

Access to resources Recommend Favorite